Insulin’s Steep Price Leads To Deadly Rationing
Alec Raeshawn Smith was 23 when diagnosed with Type 1 diabetes, and 26 when he died. He couldn't afford $1,300 per month for his insulin and other diabetes supplies. So he tried to stretch the doses.
The independent source for health policy research, polling, and news.
1,641-1,660 of 3,779 results
Alec Raeshawn Smith was 23 when diagnosed with Type 1 diabetes, and 26 when he died. He couldn't afford $1,300 per month for his insulin and other diabetes supplies. So he tried to stretch the doses.
California frequently innovates to address its wide-ranging health care needs, but it has not always achieved its aims. A series of articles in the journal Health Affairs shows, among other things, that efforts to care for HIV patients, provide better access to reproductive services for low-income women and fill gaps in primary care have sometimes fallen flat.
Two-thirds of Americans worry about unexpectedly large bills from doctors, hospitals or other medical providers, a poll shows. Four in 10 have received one in the past year.
On Wednesday, a federal judge in Fort Worth, Texas, is set to hear arguments from Republican attorneys general who want him to strike down the federal health law and from Democratic counterparts who say the law is constitutional and should remain.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico answer listeners’ questions about health policy and politics.
The story of a Texas teacher who faced a surprise “balance bill” of almost twice his annual salary gets a surprise happy ending.
The Group Insurance Board reversed a decision made last year to bar coverage of transgender hormone therapy and surgery for public workers.
The column, which began in 2010 shortly after the federal health law was signed, helps explain how that law affected Americans. Michelle Andrews, the author, will continue to report for KHN.
A Texas teacher, 44, faces a “balance bill” of almost twice his annual salary for a heart attack he never expected to have.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico discuss Senate action on health funding and opioid legislation, the state of the individual insurance market and consternation over expiration dates on EpiPens, the self-injected allergy remedy. Also, could an otter with asthma signal a potential public health crisis?
California’s third-largest insurer faces anger from customers in the individual market who unexpectedly lost their insurance despite paying premiums faithfully. In its recently filed lawsuit, the company blamed a contractor for “egregious” billing problems.
Critics worry about the message federal officials are sending by approving a new birth control option, which uses a mobile phone app for women to track their body temperature and menstrual cycle to avoid pregnancy. But the more choices the better, some reproductive health experts say.
Even as it chips away at Obamacare, the Trump administration is solidly behind state-based initiatives to cover high-cost patients, known as “reinsurance” programs. It approved two more last month.
Many insurers added surcharges to policies they sold to individuals last year to make up for a cut in federal funding. Now, federal officials suggest that states encourage insurers to sell policies without those surcharges outside of the marketplace to help people who don’t get a premium subsidy.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner talk about the latest Trump administration efforts to address high drug prices, what’s next for short-term health insurance plans and insider trading charges against a New York GOP congressman.
Federal law bars insurers from using these test results for health coverage, but they can influence whether you get a plan covering long-term care.
Young physicians are pushing the medical establishment to rethink its long-held opposition. The political fallout could be substantial.
© 2026 KFF